BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.205
+0.005 (0.42%)
At close: Mar 24, 2026, 4:00 PM EDT
1.246
+0.041 (3.38%)
After-hours: Mar 24, 2026, 7:52 PM EDT
BioCardia Market Cap
BioCardia has a market cap or net worth of $13.18 million as of March 24, 2026. Its market cap has increased by 9.76% in one year.
Market Cap
13.18M
Enterprise Value
8.53M
1-Year Change
9.76%
Ranking
Category
Stock Price
$1.21
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $13.18M, a decrease of -54.66%. That is a compound annual growth rate of -8.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 12.74M | -4.00% |
| Dec 31, 2025 | 13.27M | 32.74% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phio Pharmaceuticals | 14.29M |
| Hoth Therapeutics | 13.93M |
| IO Biotech | 13.74M |
| Genenta Science | 13.40M |
| Polyrizon | 13.31M |
| Jupiter Neurosciences | 13.20M |
| Quoin Pharmaceuticals | 12.93M |
| Kairos Pharma | 12.89M |